Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ayesha Mahbub"'
Autor:
Oluwaseun Ogunsakin, Terence Tumenta, Scarlet Louis-Jean, Ayesha Mahbub, Peterson Rabel, Tolu Olupona, Shaheen Alam
Publikováno v:
Case Reports in Psychiatry, Vol 2020 (2020)
Levetiracetam is a second-generation antiepileptic drug that is chemically unrelated to other antiepileptic drugs. Levetiracetam is a broad-spectrum antiseizure medication that is approved as an adjunctive therapy in the treatment of partial and gene
Externí odkaz:
https://doaj.org/article/36c1452f635441bc99ec2f6859eaaf29
Autor:
Olusegun Popoola, Olaniyi Olayinka, Heela Azizi, Chiedozie Ojimba, Tasmia Khan, Jisha Kallikkadan, Maleeha Ahmad, Joshua Jay, Cecilia Canale, Sherina Langdon, Alexa Kahn, Deepa Nuthalapati, Sinthuja Jayaraj, Ayesha Mahbub, Olalekan Olaolu, Kodjovi Kodjo, Tolu Olupona, Carolina Nisenoff, Ayodeji Jolayemi
Publikováno v:
Case Reports in Psychiatry, Vol 2019 (2019)
Agenesis of the corpus callosum is a rare congenital defect that has been linked to psychiatric disorders, cognitive deficits, learning disabilities, and developmental delays. We present the case of a patient with partial agenesis of the corpus callo
Externí odkaz:
https://doaj.org/article/962208858a1d4ceea2e2d2121b2b2b1a
Autor:
Peterson Rabel, Terence Tumenta, Tolu Olupona, Shaheen Alam, Oluwaseun Ogunsakin, Scarlet Louis-Jean, Ayesha Mahbub
Publikováno v:
Case Reports in Psychiatry
Case Reports in Psychiatry, Vol 2020 (2020)
Case Reports in Psychiatry, Vol 2020 (2020)
Levetiracetam is a second-generation antiepileptic drug that is chemically unrelated to other antiepileptic drugs. Levetiracetam is a broad-spectrum antiseizure medication that is approved as an adjunctive therapy in the treatment of partial and gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edeffbc6ff9871eb5b2a4d4ec440f856
http://europepmc.org/articles/PMC7450317
http://europepmc.org/articles/PMC7450317
Autor:
Shantale Williams, Tasmia Khan, Oluwole Jegede, Ahmed Ferdous Saad, Chiedozie Ojimba, Olaniyi Olayinka, Hashem Kalbouneh, Ayotomide Oyelakin, Ali Malik, Yu Hao Zeng, Alexa Kahn, Dina Rimawi, Ayodeji Jolayemi, Chidubem Matthew Obegolu, Ayesha Mahbub, Deepa Nuthalapati, Heela Azizi, Kodjovi Kodjo, Jisha Kallikkadan, Rana Alzear, Olusegun Popoola, Sherina Langdon
Publikováno v:
International Journal of Innovative Research in Medical Science. 3
Background: Negative symptoms of schizophrenia have been demonstrated to be due to decreased dopamine in the mesocortical pathways. Stimulant medications are a class of medications that can increase dopamine activity in the mesocortical pathway. Case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf434491e2abc37cde8043d14c2fd41a
https://doi.org/10.23958/ijirms/vol03-i08/08
https://doi.org/10.23958/ijirms/vol03-i08/08